ASML Investors Press Executives on Outlook Despite Bookings Beat
Video: iPhone 17 Pro Long Term Review
Moderna Inc.'s CEO said the company doesn't plan to invest in new late-stage vaccine trials due to growing opposition to immunizations from US officials